Tazneo 4.5 Injection
Marketer
Neovita Biopharmaceutical Pvt Ltd
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Tazneo 4.5 Injection
Combiflox 4.5 Injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by medical professionals, its dosage and frequency are determined by your physician based on illness severity. Strict adherence to prescribed usage is crucial. Commonly reported side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin rashes, and localized injection site reactions (pain, swelling, redness). Persistent or worsening side effects necessitate immediate medical consultation. Prior to treatment, inform your doctor of any antibiotic allergies, kidney, or liver impairments; adjustments to dosage or alternative medications may be necessary. Under medical guidance, this injection is generally considered safe for pregnant and breastfeeding individuals.
Uses of Tazneo 4.5 Injection
Infections caused by bacteria
Major Benefits of Tazneo 4.5 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Tazneo 4.5 Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Tazneo 4.5 Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
How Tazneo 4.5 Injection works:
The injectable drug Tazneo 4.5 combines piperacillin, an antibiotic that disrupts bacterial cell wall synthesis, with tazobactam, a beta-lactamase inhibitor. This combination boosts piperacillin's effectiveness by overcoming bacterial resistance mechanisms, thereby enhancing its antibacterial action.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent alcohol and Tazneo 4.5 Injection use.
PregnancySAFE IF PRESCRIBED
The use of Tazneo 4.5 Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Tazneo 4.5 poses no known breastfeeding risk. Research in humans indicates minimal to negligible drug transfer via breast milk, presenting no apparent harm to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Tazneo 4.5 Injection on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Individuals with impaired kidney function should use Tazneo 4.5 Injection cautiously. Dosage modification of Tazneo 4.5 Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Tazneo 4.5 Injection in patients with hepatic impairment appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Tazneo 4.5 Injection :
Should you forget a scheduled Tazneo 4.5 Injection, seek your physician's advice.
Facts to Know About Tazneo 4.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |



